AIM ImmunoTech (AIM) Stock Price, Quote, News & History

Comments

AIM ImmunoTech Inc (AIM) Stock Price, Quote, News & History

AIMAMEX

Trade with Public

$0.6998

-0.0002-0.03%

Last update: Mar 11, 9:14 AM

OverviewNews Earnings Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

-

Close

-

Volume / Avg.

4.99K / 1.40M

Day Range

- - -

52 Wk Range

0.06 - 20.33

Market Cap

$2.79M

P/E Ratio

-

Dividend Yield

-

Exchange

AMEX

RSI

36

Short Interest

3.67%

Days to Cover

1

Recent AIM ImmunoTech Inc News

Nasdaq Dips 200 Points; Alphabet Posts Upbeat Earnings

Avi Kapoor

Crude Oil Gains Over 1%; UnitedHealth Earnings Miss Views

Avi Kapoor

US Stocks Mixed; Procter & Gamble Posts Upbeat Earnings

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-12.93M

Investing Cash Flow (TTM)

5.65M

Financing Cash Flow (TTM)

8.71M

Free Cash Flow (TTM)

-13.33M

Capital Expenditure (TTM)

-402.00K

Net Change in Cash (TTM)

1.43M

Analyst Trends and Forecast

1

Oct 25

1

Dec 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$2.88M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

6.61

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-2594.55%

Earnings Yield % (FWD)

-735.77%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$1.44

Company Debt

Total Debt

$1.88M

LT Debt

-

LT Debt Issuance (TTM)

$250.00K

LT Debt Repayment (TTM)

-$911.00K

Total Cash

$2.35M

Debt to Equity

-

Issuance of Debt (TTM)

-$661.00K

Repayment of Debt (TTM)

-$911.00K

Key Statistics

Open

-

Close

-

Volume / Avg.

4.99K / 1.40M

Day Range

- - -

52 Wk Range

0.06 - 20.33

Market Cap

$2.79M

P/E Ratio

-

Dividend Yield

-

Exchange

AMEX

RSI

36

Short Interest

3.67%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

AIM ImmunoTech Inc is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders, and to treat cancers for which there are currently inadequate ...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy AIM ImmunoTech (AIM) stock?

A

You can purchase shares of AIM ImmunoTech (AMEX:AIM) through any online brokerage.

View our list of the best stock brokerages

Q

Who are AIM ImmunoTech (AIM) competitors?

A

Other companies in AIM ImmunoTech’s space includes: Dermata Therapeutics Inc (NASDAQ:DRMA), Ernexa Therapeutics Inc (NASDAQ:ERNAW), Geovax Labs Inc (NASDAQ:GOVX), Genprex Inc (NASDAQ:GNPX) and AquaBounty Technologies Inc (NASDAQ:AQB).

Q

What is the forecast, or price target, for AIM ImmunoTech (AIM) stock?

A

AIM ImmunoTech has a consensus price target of $11.50.

Q

What is the current price for AIM ImmunoTech (AIM)?

A

The stock price for AIM ImmunoTech (AMEX: AIM) is $0.6998 last updated March 11, 2026 at 9:14 AM EDT.

Q

Does AIM ImmunoTech (AIM) pay a dividend?

A

There are no upcoming dividends for AIM ImmunoTech.

Q

When is AIM ImmunoTech (AMEX:AIM) reporting earnings?

A

AIM ImmunoTech does not have any upcoming earnings scheduled.

Q

Is AIM ImmunoTech (AIM) going to split?

A

There is no upcoming split for AIM ImmunoTech.

Q

What sector and industry does AIM ImmunoTech (AIM) operate in?

A

AIM ImmunoTech is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.

People Also Watch

Dermata Therapeutics Inc

NASDAQ:DRMA

$1.26

-0.79%

Ernexa Therapeutics Inc

AquaBounty Technologies Inc

NASDAQ:AQB

$0.77

-17.07%

Indaptus Therapeutics Inc

NASDAQ:INDP

$1.86

-0.53%

Biodexa Pharmaceuticals PLC

NASDAQ:BDRX

$0.92

-3.00%

Ensysce Biosciences Inc

NASDAQ:ENSC

$0.49

-0.55%

Key Statistics

Open

-

Close

-

Volume / Avg.

4.99K / 1.40M

Day Range

- - -

52 Wk Range

0.06 - 20.33

Market Cap

$2.79M

P/E Ratio

-

Dividend Yield

-

Exchange

AMEX

RSI

36

Short Interest

3.67%

Days to Cover

1

Recent AIM ImmunoTech Inc News

Nasdaq Dips 200 Points; Alphabet Posts Upbeat Earnings

Avi Kapoor

Crude Oil Gains Over 1%; UnitedHealth Earnings Miss Views

Avi Kapoor

US Stocks Mixed; Procter & Gamble Posts Upbeat Earnings

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-12.93M

Investing Cash Flow (TTM)

5.65M

Financing Cash Flow (TTM)

8.71M

Free Cash Flow (TTM)

-13.33M

Capital Expenditure (TTM)

-402.00K

Net Change in Cash (TTM)

1.43M

Analyst Trends and Forecast

1

Oct 25

1

Dec 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$2.88M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

6.61

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-2594.55%

Earnings Yield % (FWD)

-735.77%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$1.44

Company Debt

Total Debt

$1.88M

LT Debt

-

LT Debt Issuance (TTM)

$250.00K

LT Debt Repayment (TTM)

-$911.00K

Total Cash

$2.35M

Debt to Equity

-

Issuance of Debt (TTM)

-$661.00K

Repayment of Debt (TTM)

-$911.00K

Key Statistics

Open

-

Close

-

Volume / Avg.

4.99K / 1.40M

Day Range

- - -

52 Wk Range

0.06 - 20.33

Market Cap

$2.79M

P/E Ratio

-

Dividend Yield

-

Exchange

AMEX

RSI

36

Short Interest

3.67%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

AIM ImmunoTech Inc is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders, and to treat cancers for which there are currently inadequate ...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry